Mainstream

Apellis Pharmaceuticals GAAP EPS of -$0.33 beats by $0.15, revenue of $178.5M misses by $10.15M

Apellis Pharmaceuticals GAAP EPS of -$0.33 beats by $0.15, revenue of $178.5M misses by $10.15M

Post ContentaplsRead More

You might also be interested in reading AI firm Rabbit rejects Coffeezilla’s NFT scam accusation.

July 31, 2025
In Mainstream